Literature DB >> 23449126

Enzymatically generated hydrogen peroxide reduces the number of acne lesions in acne vulgaris.

Neelam Muizzuddin1, Steven Schnittger, Wanda Maher, Daniel H Maes, Thomas Mammone.   

Abstract

A major component to the etiology of acne is the growth and invasion by Propionibacterium acnes. Hydrogen peroxide is an excellent antimicrobial agent but is unstable in most formulations. We have developed a hydrogen peroxide generation system using the enzyme glucose oxidase and glucose. This system is stable in a simple formulation and nonirritating. In a short-term clinical study (4 days), this formulation was effective in reducing the individual lesion size and total number of inflammatory acne lesions. There was a 68% reduction in acne-induced inflammation and 61% reduction in acne size within 4 days of treatment. A long-term clinical study (6 weeks in use) displayed 56% reduction in total number of inflamed lesions and a 45% reduction in noninflamed lesions after 6 weeks. This suggests that topical enzymatically generated hydrogen peroxide may help alleviate acne.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23449126

Source DB:  PubMed          Journal:  J Cosmet Sci        ISSN: 1525-7886            Impact factor:   0.948


  3 in total

1.  Results of a Multicenter, Randomized, Controlled Trial of a Hydrogen Peroxide-based Kit versus a Benzoyl Peroxide-based Kit in Mild-to-moderate Acne.

Authors:  Stefano Veraldi; Giuseppe Micali; Enzo Berardesca; Federica Dall'Oglio; Jo Linda Sinagra; Elena Guanziroli
Journal:  J Clin Aesthet Dermatol       Date:  2016-10-01

Review 2.  Innovative drugs, chemicals, and enzymes within the animal production chain.

Authors:  Yousef I Hassan; Ludovic Lahaye; Max M Gong; Jian Peng; Joshua Gong; Song Liu; Cyril G Gay; Chengbo Yang
Journal:  Vet Res       Date:  2018-07-31       Impact factor: 3.683

Review 3.  p53: key conductor of all anti-acne therapies.

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2017-09-19       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.